hotspot -WSS

hotspot

author：Wikipedia 2025-09-29 20:52:06 - browse：86

A medical device to treat below-the-knee chronic limb-threatening ischemia, Esprit BTK resorbable scaffold, is shown consisted of pieces of geometric shapes that lined up into a pipe on a blue background — health tech coverage from STAT — Cardiovascular doctors are optimistic about Abbott’s new below-knee stent that disappears into the blood vessel’s walls over the course of three years. Courtesy Abbott

An Abbott device that failed in heart disease patients is getting a new life in patients with severe vascular disease.

The device is a below-knee stent that widens clogged blood vessels, and then vanishes into the vessel’s walls over the course of three years. It also delivers a drug that prevents scar tissue from forming — a common risk factor with traditional metal stents that further narrow the vessel.

Abbott’s first dissolvable stent, for coronary artery disease, received Food and Drug Administration approval in 2016. But the company voluntarily pulled the product from the market just over a year later due to “low commercial uptake.” The device also received mixed results in clinical trials.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Anger, defiance, fear over Supreme Court decision to block student loan forgiveness

WSS

GOP inquiry over gain

The simple reason for the increase in autism diagnosis

Belarusian journalist sentenced to 4 years in prison as crackdown continues

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

Addiction doctors spar with methadone clinics over legislation

Report: NIH

entertainment

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

hotspot

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Lab trade group sues FDA to halt regulation of lab

The cancer drug shortage isn’t new — and neither are the solutions

Anger, defiance, fear over Supreme Court decision to block student loan forgiveness

Heart attack and stroke risk calculators need revising

GOP hopefuls to address prominent, controversial group questioning what's taught in schools

Moonlake's readout produced a cash windfall. Risks remain

Biohaven protein

The high cost of giving birth even with insurance

Ukrainian soldiers say they owe lives to US

Wikipedia

AI used to predict Covid

Startling documents reveal new facets of Sacklers' opioid empire

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

Adam's Biotech Scorecard: Do Sarepta's exon

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

UnitedHealth starts bidding war with $3.3 billion offer for Amedisys

leisure time

hotspot

entertainment

hotspot